Centre for Respiratory Diseases and Meningitis
MUSIC-Flu is a prospective, non-interventional cohort study investigating how immune responses protect young children against influenza infection and illness. Influenza causes substantial illness and death globally, with a particularly high burden in sub-Saharan Africa. In South Africa, young children experience the highest infection rates and play a major role in transmission. While vaccines exist, their effectiveness is moderate, and the immune mechanisms that drive protection, especially those that reduce transmission, are not fully understood. This study focuses on identifying both systemic (blood-based) and mucosal (respiratory tract) immune markers that predict protection. Understanding these correlates is essential for improving vaccine design, accelerating evaluation of new vaccines, and informing immunisation strategies in similar settings. The study is being conducted in Jouberton, North West Province, among healthy children aged 2–5 years. Recruitment began in March 2026, with participants enrolled through local clinics. Children are followed intensively throughout the influenza season, with active follow-up from April to October 2026. This includes frequent nasal swab collection to detect infection, regular symptom monitoring, and repeated collection of blood and mucosal samples to measure immune responses over time. By combining detailed clinical follow-up with high-resolution immunological data, MUSIC-Flu provides a unique opportunity to understand how immunity develops, wanes, and protects against infection, illness, and onward transmission in a high-burden setting.
Primary objectives:
Secondary objectives:
MUSIC-Flu will generate critical evidence on how immunity to influenza functions in young children, particularly at the site of infection in the respiratory tract. The findings will support the development of more effective influenza vaccines, including those that reduce transmission, and inform regulatory pathways by identifying improved immune correlates of protection. In addition, the study will guide vaccination strategies in South Africa and other low- and middle-income settings, contributing to efforts to reduce the overall burden of influenza, especially among vulnerable populations. Ultimately, this work will help bridge key knowledge gaps needed to strengthen influenza prevention in high-burden settings.
The study was approved by the University of the Witwatersrand Human Research Ethics Committee (Medical) reference 251114.
